Kenvue Inc
NYSE:KVUE
Intrinsic Value
Kenvue Inc is a US-based company operating in Personal Care Products industry. [ Read More ]
The intrinsic value of one KVUE stock under the Base Case scenario is 20.085 USD. Compared to the current market price of 20.2626 USD, Kenvue Inc is Overvalued by 1%.
Valuation Backtest
Kenvue Inc
Run backtest to discover the historical profit from buying and selling KVUE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Kenvue Inc
Current Assets | 6.1B |
Cash & Short-Term Investments | 1.4B |
Receivables | 2.1B |
Other Current Assets | 2.7B |
Non-Current Assets | 21.7B |
PP&E | 2.2B |
Intangibles | 18.9B |
Other Non-Current Assets | 642m |
Current Liabilities | 5.5B |
Accounts Payable | 2.5B |
Accrued Liabilities | 2.4B |
Short-Term Debt | 599m |
Non-Current Liabilities | 11.2B |
Long-Term Debt | 7.7B |
Other Non-Current Liabilities | 3.5B |
Earnings Waterfall
Kenvue Inc
Revenue
|
15.4B
USD
|
Cost of Revenue
|
-6.7B
USD
|
Gross Profit
|
8.7B
USD
|
Operating Expenses
|
-5.6B
USD
|
Operating Income
|
3.1B
USD
|
Other Expenses
|
-1.4B
USD
|
Net Income
|
1.7B
USD
|
Free Cash Flow Analysis
Kenvue Inc
KVUE Profitability Score
Profitability Due Diligence
Kenvue Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Kenvue Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
KVUE Solvency Score
Solvency Due Diligence
Kenvue Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Kenvue Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KVUE Price Targets Summary
Kenvue Inc
According to Wall Street analysts, the average 1-year price target for KVUE is 22.5284 USD with a low forecast of 18.18 USD and a high forecast of 26.292 USD.
Ownership
KVUE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
KVUE Price
Kenvue Inc
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -34% |
Market Capitalization | 38.8B USD |
Shares Outstanding | 1 915 057 047 |
Percentage of Shares Shorted | 1.89% |
KVUE News
Last Important Events
Kenvue Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Kenvue Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kenvue Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Skillman, New Jersey and currently employs 22,200 full-time employees. The company went IPO on 2023-05-04. Kenvue Inc. is a consumer health company. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment product categories include cough, cold and allergy; pain care; and other self-care (digestive health, smoking cessation and other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment product categories include oral care, baby care and other essential health (women’s health and wound care). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. Its network includes 114 distribution centers and 38 customer service centers across all its regions. Its subsidiaries include JNTL (APAC) HoldCo 2 LLC and JNTL (APAC) HoldCo 2 LLC.
Contact
IPO
Employees
Officers
The intrinsic value of one KVUE stock under the Base Case scenario is 20.085 USD.
Compared to the current market price of 20.2626 USD, Kenvue Inc is Overvalued by 1%.